Featured
-
KwikClick Is Redefining The Influencer Landscape…Here’s Why Its Stock Presents An Investment Opportunity Too Good To Ignore ($KWIK)
KwikClick, Inc. (OTC Pink: KWIK) is an under-the-radar company once again proving that stock prices rarely reflect fair value. In…
Read More » -
Digital Brands Group Expects To Close Sundry Acquisition In Q3, Investors Send Shares 10% Higher ($DBGI)
Digital Brands Group, Inc. (NASDAQ: DBGI, $DBGI) stock is catching a bid, up about 10% over the past week. And…
Read More » -
Earth Life Sciences Stock Continues To Run, 174% Higher Since May ($CLTS)
Earth Life Sciences (OTC Pink: CLTS, $CLTS) continues to run higher. On Monday, it added another intraday 5% increase to…
Read More » -
Pay Attention: Adamas One Corp. Is Targeting A More Than $100 Billion Diamond Market Opportunity
Pay attention to Adamas One Corporation. They are changing the synthetic diamond industry and, from an investor’s perspective, can do…
Read More » -
Digital Brands Group, Inc. Imminent Sundry Acquisition Could Blow The Lid Off This Percolating Stock ($DBGI)
If anyone had suggested a year ago that Digital Brands Group’s (NASDAQ: DBGI, $DBGI) stock price would be consolidating at…
Read More » -
Earth Life Sciences Stock Surges 171% Since May; Accretive Acquisition Expected To Fuel Further Upside ($CLTS)
Earth Life Sciences (OTC Pink: CLTS, $CLTS) is on fire, surging more than 94% on volume over 10X its recent…
Read More » -
Acurx Pharmaceuticals Stock Is Higher By 42% In June…Here’s Why The Bears Are Staying Away ($ACXP)
Markets have been terrible. In fact, few stocks have weathered the bearish storm as all major indexes break below bear…
Read More » -
Taking Exception To The Bearish Coverage Of Digital Brands Group, Inc… Here’s Why ($DBGI)
An article published by Retail Dive on April 1, 2022, may have awakened the bears, but its information could lead them to…
Read More » -
Adamas One Corp. Is Cut And Polished For Success, Seizes A More Than $100 Billion Diamond Market Opportunity
Diamonds aren’t just a girl’s best friend – they also present massive revenue-generating opportunities for innovative companies changing the landscape…
Read More » -
Acurx Pharmaceuticals Update Validates Front Line CDI Treatment In Play ($ACXP)
Acurx Pharmaceuticals (NASDAQ: ACXP) provided an update showing that its position to bring a front-line treatment against CDI is on…
Read More »